Susquehanna International Group’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,900
Closed -$78.5K 13595
2023
Q1
$78.5K Sell
10,900
-22,200
-67% -$172K ﹤0.01% 11445
2022
Q4
$272K Sell
33,100
-33,900
-51% -$316K ﹤0.01% 9333
2022
Q3
$708K Buy
67,000
+33,500
+100% +$356K ﹤0.01% 7535
2022
Q2
$310K Buy
33,500
+22,100
+194% +$181K ﹤0.01% 9486
2022
Q1
$78K Sell
11,400
-32,200
-74% -$207K ﹤0.01% 12071
2021
Q4
$351K Sell
43,600
-159,900
-79% -$1.06M ﹤0.01% 10107
2021
Q3
$1.25M Buy
+203,500
New +$772K ﹤0.01% 6979

Other funds holding BLU

Susquehanna International Group's BLU Position: Q3 2022 in Review

Susquehanna International Group sold out of BELLUS Health Inc. (BLU) in Q3 2022, closing a stake of 31,584 shares — an estimated $336K sold.

Susquehanna International Group first reported a position in BLU in Q4 2019 and held it in 8 quarters. The position peaked at $1.79M in Q1 2020. 116 funds tracked by Wall St. Rank hold BLU as of Q3 2022.

  • Susquehanna International Group reported no remaining BELLUS Health Inc. position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 31,584 BELLUS Health Inc. shares in Q3 2022, an estimated $336K.
  • Susquehanna International Group first reported a position in BELLUS Health Inc. in Q4 2019 and held it in 8 quarters.
  • Susquehanna International Group's BELLUS Health Inc. position peaked at $1.79M in Q1 2020.
  • 116 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.